Listonstreetpulse.com announces that Arrayit Corporation (OTC: ARYC) has received a $94,500 purchase order from a prestigious medical research center in Boston, Massachusetts, USA for the company’s SpotBot® Titan Protein Edition Microarray Arrayer.
The Arrayit SpotBot® Titan is a high-speed automated robot that empowers customers to manufacture microarrays, which are glass substrate slides containing microscopic collection of genes, proteins and other molecules used to explore human genome, decipher human disease, and analyze the mode of pharmaceutical compound activity among many scientific applications.
Arrayit is the fourth largest public company in the microarray industry, following Agilent (NYSE: A), Illumina (NASDAQ: ILMN) and Affymetrix (NASDAQ: AFFX). Rising above competition, Arrayit’s patented printing technology has been used to manufacture an estimated 150,000,000 microarray devices since 1998, making the company the most prolific microarray manufacturer in the expanding billion dollar marketplace.
To read more about ARYC and subscribe to a monthly update, CEO interview etc, please click here – http://www.listonstreetpulse.com/tag/ARYC/
About Arrayit Corporation
Arrayit Corporation is a Sunnyvale, California-based company leading and empowering the genetic, research, pharmaceutical, and diagnostic communities through the discovery, development, and manufacture of proprietary life science technologies and consumables for disease prevention, treatment and cure. The company’s innovative products and services help scientists and clinicians explore the human genome as well as the genomes of plants and animals. Arrayit’s products are used by every major research center in the world.
About Liston Street Pulse
Liston Street Pulse is a leading provider of financial research. The company has significant expertise in U.S. listed small cap and micro-cap stocks. Over the years, Liston Street Pulse’s original and unbiased analysis has helped the investor community immensely.
